Pastorino and colleagues noted that defining cure in stage II and III colon cancer has been challenging for two reasons: It is difficult to determine the threshold at which the chances of relapse ...

The concept of a cure in oncology, particularly for stage II and III colon cancer (CC), has historically suffered from ...

IRCCS Ospedale Policlinico San Martino with Mayo Clinic and multiple international cancer research centers have delivered a pooled analysis indicating that colon cancer recurrence risk drops below 0.5 ...

Colon cancer recurrence risk falls below 0.5% at 6 years post-surgery, offering a practical benchmark for defining cure, according to new research.

Like with HR-positive patients, researchers found that patients with HR-negative or ER-low tumors lived longer on Enhertu than chemo after nearly three years.

Entitled “International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma,” the peer-reviewed article, published online on ...